End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.084 AUD | -1.18% | -5.62% | +42.37% |
Jun. 03 | Percheron Therapeutics Names Chief Medical Advisor | MT |
May. 29 | Percheron Therapeutics Completes Enrollment for Phase Two Muscular Dystrophy Trial; Shares Rise 3% | MT |
- Stock Market
- Equities
- PER Stock
- News Percheron Therapeutics Limited
- MarketScreener Editorial Features